|
2024
|
Invention
|
Sustained release compositions comprising micronized tolcapone. The present invention relates to ... |
|
2020
|
Invention
|
Therapy for transthyretin-associated amyloidosis. It is provided a catechol-O-methyltransferase (... |
|
2017
|
Invention
|
Therapeutic agents for use in the propylaxis and/or treatment of hyperkinetic movement disorders.... |
|
|
Invention
|
Sustained release composition comprising micronized tolcapone. The present invention relates to s... |
|
2014
|
Invention
|
Therapeutic agents for use in the prophylaxis and/or treatment of hyperkinetic movement disorders... |
|
2012
|
Invention
|
New therapy for transthyretin-associated amyloidosis. It is provided a catechol-O-methyltransfera... |
|
|
Invention
|
Use of comt inhibitors for treating transthyretin-associated amyloidosis. The present inven... |
